Declining echo exams during COVID-19 may have staggering consequences
Analysis powered by the CardioCare program’s proprietary artificial intelligence algorithm and performed using rolling 30-day average to normalize against variation. *These data are representative of transthoracic echocardiograms across 25 hospitals in the U.S. from January 1, 2020–May 12, 2020.
Receive CardioCare program news and updatesSign up
Severe Aortic Stenosis (AS)
Survival after onset of symptoms for severe AS is as low as 50% at 2 years and 20% at 5 years.†
Severe Mitral Regurgitation (MR)
For patients with severe MR, survival is as low as 50% at 5 years, with hospitalization rates for heart failure as high as 90% over the same period.‡
† Otto CM. Heart 2000;84:211–21.
‡ Goel SS, et al. JACC 2014 Jan21;63(2):185–6.
Current patterns may leave patients with structural heart disease undiagnosed.
By automating clinical workflow, the CardioCare program provides visibility to all patients in your system with aortic stenosis and mitral regurgitation, enabling providers to prioritize care for the most critical patients.
The CardioCare program enables structural heart program growth by providing software and services that focus on:
Maximize echo lab quality to help ensure earlier identification of disease
Improve identification of SHD and identify targeted opportunities for training and education
Streamline clinical workflow and communication between care providers to ensure timely referral to a CV specialist
Clinical consulting partners turn data analytics into actionable insights, enacting quality improvement and change management at leading institutions across the country
Using the CardioCare program, hospitals leverage unprecedented insights into their structural heart programs to drive meaningful improvements in quality and patient care.
Average increase in aortic stenosis diagnosis rates
Average increase in aortic stenosis referral rates
Analysis represents median risk share performance across 12 sites six months after program implementation.
Using data and analytics, the CardioCare program identifies gaps in the care pathway and provides nationwide benchmarking services.
The CardioCare program delivers sustainable quality improvement
Adherence to three-measurement protocol to assess AS shows improvement over time.
The CardioCare program improves the patient care pathway
echocardiograms processed from 2015-2020
of all patients met severe AS criteria
of all patients met moderate AS criteria1
1. Excludes studies with one or more severe AS values.
Partner with us as the CardioCare program delivers a robust pipeline of innovations to answer the most vexing questions faced by clinicians in the pursuit of earlier identification, management and treatment of patients with structural heart disease.
Your information has been received. An Edwards representative will contact you.
Please update to a current version of your preferred browser, this site will perform effectively on the following:Unable to update your browser?
If you are on a computer, that is maintained by an admin and you cannot install a new browser, ask your admin about it. If you can't change your browser because of compatibility issues, think about installing a second browser for browsing and keep this old one for compatibility